Literature DB >> 31427496

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.

.   

Abstract

Entities:  

Year:  2019        PMID： 31427496      PMCID： PMC7508313          DOI： 10.1212/WNL.0000000000007919

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  1 in total

1.  INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.

Authors:  Pierre-François Meyer; Jennifer Tremblay-Mercier; Jeannie Leoutsakos; Cécile Madjar; Marie-Élyse Lafaille-Maignan; Melissa Savard; Pedro Rosa-Neto; Judes Poirier; Pierre Etienne; John Breitner
Journal:  Neurology       Date:  2019-04-05       Impact factor: 9.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.